Travel sourcing and consultancy group Partnership Travel Consulting has named former Corporate Travel Management executive Maureen Brady as its chief commercial officer, a new position for the group.

PTC Therapeutics' Kebilidi gains FDA accelerated approval as the first brain-administered gene therapy in the U.S. for AADC ...

Barclays raised the firm’s price target on PTC Therapeutics (PTCT) to $45 from $43 and keeps an Equal Weight rating on the shares. After ...

Sami Corwin has given his Buy rating due to a combination of factors that favor PTC Therapeutics’ market position. The recent FDA approval of Kebilidi, a groundbreaking gene therapy for AADC ...

This is the first gene therapy for AADC deficiency to receive US regulatory approval and the first that can be administered directly to the brain.

PTC Therapeutics (PTCT) stock on watch as company receives FDA approval for gene therapy Kebilidi for AADC deficiency. Read ...

Raising and narrowing 2024 guidance ranges: Adjusted EBITDA of $750 to $780 million and Adjusted Free Cash Flow of $265 to $285 million. Reaffirming 2025 guidance ranges: Adjusted EBITDA of $925 to $1 ...

If the Personal Finance Society (PFS) decided to cut ties with its parent organisation the Chartered Insurance Institute (CII) it would not be an easy break and members would suffer, the latter’s CEO ...

Over 1,000 companies, including Muthoot Finance and Grasim, will release Q2FY24-25 results today. The Niva Bupa <a ...

Modifying Treatment for AADC Deficiency in the United States SOLANA BEACH, CA / / November 13, 2024 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the 'Company'), a global therapy-enabling platform company ...

Renesas Electronics Corporation, a supplier of advanced semiconductor solutions, today announced the world's first “8-in-1” ...

Personal Finance Society (PFS) chair Christine Elliott has admitted the ongoing dispute between the organisation and the Chartered Insurance Institute (CII) is professionally embarrassing but assured ...